On January 27, 2021, the Biotechnology Innovation Organization (BIO) published 100 Days of Innovation—a blueprint for the public and private sector to work together to mobilize innovation during the first 100 plus days of the new Biden-Harris Administration.
BIO is a powerful voice as the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad.
The blueprint states that “our nation is at a critical juncture and how we approach the next 100 days will be essential in terms of ending the pandemic and rebuilding our economy in a way that is more resilient, more dynamic, and more inclusive.”
Six priorities are identified, largely focusing on COVID-19 and public health, but climate change is not overlooked—BIO specifically identifies as a priority, driving “economic revival and resiliency through adoption of advanced biotechnology solutions.”
Biotechnology companies are developing important solutions in the face of climate change, including low-carbon fuels, bio-based plastics and adaptation technologies such as gene editing techniques that will ensure that plant and animal food sources are more sustainable and resilient in the face of climate threats.
BIO calls for the development of streamlined and expedited regulatory pathways for breakthrough technology solutions to climate change, and for incentives to adopt sustainable agricultural practice and low-carbon fuels.
(Image acknowledgement: BIO)
This blog post is brought to you by Draper & Draper LLC, a law firm devoted to international arbitration, resolution of natural resources and renewable energy disputes, climate change innovation and patents.
コメント